Corrigendum to “Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology” [J. Cardiol. 72 (2) (2018) 113–119] (Journal of Cardiology (2018) 72(2) (113–119), (S0914508718300546) (10.1016/j.jjcc.2018.01.017))

The authors regret that the figure regarding the answer spectrum to “What anti-thrombotic therapy do you prefer to use in AF patients 1-year after stent implantation?” had a wrong value within a column. In this Fig. 4 the yellow section (aspirin + OAC) at the column of 2016 actually corresponded to 45% rather than 49%. Although this was due to simple calculation error, we would like to humbly apologize for any convenience caused in readers of this journal.